Skip to content

American authorities withdraw visas for Indian business leaders and their families due to their involvement in smuggling precursor chemicals used in the production of fentanyl.

U.S. Embassy affirms that visa measures were undertaken based on Immigration and Nationality Act provisions

U.S. Cancels Visas for Indian Business Leaders and Their Families due to Involvement in Fentanyl...
U.S. Cancels Visas for Indian Business Leaders and Their Families due to Involvement in Fentanyl Precursor Smuggling

American authorities withdraw visas for Indian business leaders and their families due to their involvement in smuggling precursor chemicals used in the production of fentanyl.

U.S. Embassy in New Delhi Committed to Combating Illicit Drug Trafficking

The U.S. Embassy in New Delhi has reaffirmed its commitment to combating illicit drug trafficking, particularly focusing on the stoppage of the flow of fentanyl and its precursors.

In a statement, the embassy expressed its gratitude for the close cooperation it has received from the Government of India in this fight against drug trafficking. The embassy's commitment extends to consequences for individuals and organizations involved in the illegal production and trafficking of drugs to the United States. This may include visa revocations, with some individuals and organizations being denied access to the United States.

Recent actions by the U.S. Department of Justice highlight the embassy's resolve. The Department has taken legal action against India-based companies for their role in drug trafficking. The US Federal Drug Enforcement Administration, for instance, charged Vasudha Pharma Chem Ltd and three of its senior employees with similar offenses.

Two Indian companies, Raxuter Chemicals and Athos Chemicals, have also been indicted in the U.S. for importing ingredients used in opioid fentanyl, another indication of the embassy's focus on this particular drug.

It is important to note that the list of major drug transit or illicit drug-producing countries does not necessarily reflect the counter-drug efforts of the listed governments. India, as one of 23 major drug transit or illicit drug-producing countries named by the US President Donald Trump, is actively working to combat this issue.

Despite these actions, there are currently no relevant search results indicating which other Indian companies have been accused by the U.S. Justice Department in recent months of illegally importing fentanyl precursors in violation of U.S. federal laws.

The embassy's efforts in this area are ongoing, and it continues to prioritize the protection of its citizens and the international community from the scourge of drug trafficking.

Read also:

Latest